|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$3.19 |
$3.32 |
$3.13 |
$3.25 |
219.40K | 04/19/2024 |
$3.26 |
$3.42 |
$3.21 |
$3.40 |
926.20K | 04/22/2024 |
$3.30 |
$3.48 |
$3.30 |
$3.45 |
294.90K | 04/23/2024 |
$3.48 |
$3.75 |
$3.45 |
$3.65 |
211.80K | 04/24/2024 |
$3.64 |
$3.73 |
$3.60 |
$3.63 |
97.80K |
|
ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. | |
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on April 18, 2024, ABIO opened at $3.19, traded as high as $3.32 and as low as $3.13, and closed at $3.25. Trading volume was a total of 219.40K shares. On April 19, 2024, ABIO opened at $3.26, traded as high as $3.42 and as low as $3.21, and closed at $3.40. Trading volume was a total of 926.20K shares. On April 22, 2024, ABIO opened at $3.30, traded as high as $3.48 and as low as $3.30, and closed at $3.45. Trading volume was a total of 294.90K shares. On April 23, 2024, ABIO opened at $3.48, traded as high as $3.75 and as low as $3.45, and closed at $3.65. Trading volume was a total of 211.80K shares. On April 24, 2024, ABIO opened at $3.64, traded as high as $3.73 and as low as $3.60, and closed at $3.63. Trading volume was a total of 97.80K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$199.08 |
|
End price/share: |
$3.63 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.18% |
|
Average Annual Total Return: |
-33.01% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$182.21 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $3.25 | 04/19/2024 | $3.40 | 04/22/2024 | $3.45 | 04/23/2024 | $3.65 | 04/24/2024 | $3.63 |
|
|